Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP-1) receptors. It is primarily studied in metabolic research for its effects on glucose regulation, insulin signaling, and appetite modulation. It has also been examined for its role in energy balance and weight related pathways. For laboratory research only — not for human use.